As 2023 concludes, Biocair, an established global leader in life sciences logistics, proudly announces a year of remarkable achievements. With significant strides in sustainability, strategic partnerships and global expansion, Biocair affirms its commitment to being the specialist in temperature-controlled logistics for the life sciences industry.
Sustainability at the forefront:
Cancer Research UK has appointed industry veteran Dr Lars Erwig as the new director for its Centre for Drug Development, the world's only charity-funded drug development facility.
With Cancer Research UK’s aim to beat cancer, the centre has a critical role to play in partnering with others to ensure that pre-clinical and early-phase clinical projects with the highest potential for patient benefit are prioritised and rapidly advanced.
Specialist Intellectual Property law firm Reddie & Grose is delighted to introduce its brand-new podcast series, ‘Talk IP with R&G’.
Hosted by experts from across the firm, the regular podcast is a go-to resource on how businesses can make the most of their intellectual property.
Pioneer Group, a company combining laboratory development and operation with venture building, is continuing its collaboration with Innovate UK by bringing its venture development ‘Launch Programme’ to the Exploit stage of Innovate UK’s ICURe programme.
The Launch Programme welcomes invited life science founders from the ICURe Programme, as well as the Pioneer Group ecosystem, to provide support in accelerating their development from lab to market adoption.
London, UK; December 11, 2023 — AviadoBio, a pioneering gene therapy company dedicated to developing and delivering potentially transformative medicines for neurodegenerative disorders, today announced the appointment of John Isaac, Ph.D., as Chief Scientific Officer. Previous interim Chief Scientific Officer and AviadoBio co-founder, Professor Chris Shaw, will remain an active member of the leadership team and resume his prior roles as Chief Scientific and Clinical Advisor and Board Observer.
Download the My Green Lab 2023 Carbon Impact of Biotech & Pharma report now!
In an informative new blog post - AMSBIO reflects on a selection of the groundbreaking life science and biomedical research undertaken by its customers during 2023. From deciphering the intricacies of cancer progression mechanisms to revolutionising wound care, AMSBIO is delighted to have played a supporting role in these scientific endeavours.
MHA is excited to announce the appointment of Chris Liu as Partner who will lead our successful Transfer Pricing Team in the International Marketplace.
Biocair, a global leader in GDP logistics for the pharmaceutical, biotechnology and life sciences sectors, is proud to announce its partnership with Aramex Ireland to expand its presence in the Irish market.
With Biocair's focus on providing the most comprehensive time-sensitive and temperature-controlled logistics services available, and Aramex Ireland’s operations and facilities to deliver life science goods, the partnership is poised to grow an established presence in Ireland for the life science market.
The companies are working together on next-generation technology in the fast-growing field of synthetic biology. This new technology will improve the quality, speed, and cost of developing synthetic biological solutions such as life-saving vaccines, medicines, treatments, and therapies.